Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Romanoff

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|November 12, 2025
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)Robert Jeraj, Fenghai Duan, Ryan J Mattison, et al.
JAMA Neurology|July 28, 2025
Concordance Between Amyloid-PET Quantification and Real-World Visual ReadsEhud Zeltzer, Daniel R Schonhaut, Nidhi S Mundada, et al.
Radiology|April 29, 2025
Erratum for: MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
JAMA Oncology|January 18, 2019
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ TreatmentConstance D Lehman, Constantine Gatsonis, Justin Romanoff, et al.
Radiology|April 1, 2025
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
Radiology|August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Journal of Breast Imaging|February 5, 2021
Factors Affecting Image Quality and Lesion Evaluability in Breast Diffusion-weighted MRI: Observations from the ECOG-ACRIN Cancer Research Group Multisite Trial (A6702)Jennifer G Whisenant, Justin Romanoff, Habib Rahbar, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|March 12, 2026
Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individualsCharles C Windon, Elena Tsoy, Jennifer Livaudais-Toman, et al.
Radiology|September 20, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Radiology|November 17, 2020
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging TrialElizabeth S McDonald, Justin Romanoff, Habib Rahbar, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|November 12, 2025
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)Robert Jeraj, Fenghai Duan, Ryan J Mattison, et al.
JAMA Neurology|July 28, 2025
Concordance Between Amyloid-PET Quantification and Real-World Visual ReadsEhud Zeltzer, Daniel R Schonhaut, Nidhi S Mundada, et al.
Radiology|April 29, 2025
Erratum for: MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
JAMA Oncology|January 18, 2019
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ TreatmentConstance D Lehman, Constantine Gatsonis, Justin Romanoff, et al.
Radiology|April 1, 2025
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
Radiology|August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Journal of Breast Imaging|February 5, 2021
Factors Affecting Image Quality and Lesion Evaluability in Breast Diffusion-weighted MRI: Observations from the ECOG-ACRIN Cancer Research Group Multisite Trial (A6702)Jennifer G Whisenant, Justin Romanoff, Habib Rahbar, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|March 12, 2026
Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individualsCharles C Windon, Elena Tsoy, Jennifer Livaudais-Toman, et al.
Radiology|September 20, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Radiology|November 17, 2020
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging TrialElizabeth S McDonald, Justin Romanoff, Habib Rahbar, et al.
Pageof 4